|
The 6th Annual Monoclonal Antibodies 2010 is the leading event for all the professionals involved in the pharmaceuticals & biotech industry, in UK. The major focus of this conference will be on the areas such as latest bioengineering techniques, fully human mAbs, and autoimmune, solid and liquid tumors, and inflammatory diseases. Leading experts, practitioners, researchers and related professionals from all around the globe will come together to discuss key issues and the recent challenges in this sector. The conference will also include inventive workshops focused on the opportunities and challenges with antibody therapies for nervous systems disorders. It will offer an opportunity for the attendees to gain insights into the most recent topics and main drivers in mAb research and development today. The 6th Annual Monoclonal Antibodies conference 2010 features interactive panel discussion, case studies presented by innovative scientists and research leaders from big pharma and large biotech organization.
Visitor Profile
The targeted visitors at the 6th Annual Monoclonal Antibodies 2010 Conference are Directors, Heads, VPs and Managers of:
- Pharmaceutical and patent law
- Contract research organizations
- Outsourcing/contract manufacturing
- Antibody development
- CNS autoimmune and inflammatory disease research
- Preclinical/clinical research and development
- Recombinant DNA biotechnology
- Cell and molecular biology
- Business development
- New product development
- Clinical diagnostics
- Marketing
- Licensing
Organizer
Visiongain Ltd.